cindy orser

Nevada: Marijuana Testing Facility Opens For Business In Las Vegas

DigiPathLabsCetifiedQualityAndPotencyTestedToNevadaStateStandards

DigiPath Labs, the cannabis testing subsidiary of DigiPath, Inc., on Wednesday opened the doors of its Las Vegas marijuana analytical testing laboratory for business. Equipped with state of the art analytical instrumentation and operated under the direction of Cindy Orser, PhD, DigiPath Lab's flagship facility says it offers cannabis growers and marijuana-based product-makers fast and reliable results.

"This is a great day for the patients of Nevada who will benefit from medical marijuana," said DigiPath Labs president Todd Denkin. "Our analysis not only helps product producers and dispensaries screen out products with dangerous levels of contaminants, we also quantify the medicinal compounds present in samples, so patients and caregivers can choose products that have been shown to relieve their specific symptoms."

Surprisingly, compulsory cannabis testing is relatively new. The State of Colorado only began requiring product testing a year ago after a series of freakouts on edibles made the news. Washington State did not begin requiring testing for potency, contaminants, moisture and microbiology testing until 2013 when recreational cannabis became legal, even though the medicinal use of marijuana became legal in 1998.

The portfolio of cannabis testing services offered by DigiPath includes foreign matter inspection, moisture content analysis, solvent residue analysis, pesticide residue analysis, heavy metals screening, microbial screening, mycotoxin screening, and potency analysis.

Nevada: DigiPath Gets State Approval For Cannabis Testing Lab In Las Vegas

DigiPathScientistInLab

DigiPath, Inc., an independent cannabis testing and media firm, on Thursday announced that it has received approval from the state of Nevada for its DigiPath Labs subsidiary to open and operate a cannabis testing laboratory at 6450 Cameron Street, Suite 113, in Las Vegas.

DigiPath Labs is in the process of applying for construction permits, ordering equipment, and hiring staff in anticipation of opening the Cameron Street laboratory. To expedite construction, the company is working with a local architectural firm it engaged during the application process. The lab is expected to open its doors to customers in early 2015.

"We are grateful to the State of Nevada for helping to advance our goal of setting a new benchmark for medical cannabis testing and safety screening," said Todd Denkin, CEO of DigiPath, Inc.

"DigiPath Labs is dedicated to increasing transparency of the ingredients inside cannabis-based products," Denkin said. "We believe that this information will benefit patients and dispensaries by providing them with important information regarding the products being sold for consumption."

DigiPath Labs will screen medicinal cannabis for potentially harmful contaminants, including:

• Solvents
• Pesticides
• Mold
• Heavy metals, including mercury, arsenic, lead, and cadmium
• Biological toxins, such as aflatoxin, ricin, and botulinum toxins
• Residual organic chemicals used in extraction
• Microbial contaminants including E. coli, salmonella, and Aspergillus

Syndicate content